Sabra Healthcare SBRA Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $196.63M+15.5% | $187M+10.2% | $177.9M+4.5% | $172.11M+0.8% | $170.2M-1.7% | ||
| $11.75M+28.0% | $11.36M+26.4% | $10.83M+21.7% | $10.54M+23.3% | $9.18M+11.8% | ||
| $8.63M-5.8% | $7.99M-23.9% | $7.36M-37.9% | $7.76M-37.2% | $9.16M-25.9% | ||
| -$1.09M-79.1% | -$1.05M-83.4% | -$765K— | -$673K— | -$607K— | ||
| —— | —— | -$1.33M— | —— | —— | ||
| $10.16M-15.3% | $11.45M-26.0% | $11M-21.5% | $13.62M+0.9% | $12M-17.7% | ||
| —— | —— | —— | -$17.72M-379% | -$531K+87.1% | ||
| $5.62M— | $3.93M— | $2.18M— | —— | —— | ||
| $7.1M+12.1% | $7.81M+43.4% | $7.61M+37.9% | $6.81M+35.8% | $6.34M+38.4% | ||
| $366.71M+8.5% | $348.61M+12.3% | $341.15M+10.3% | $338.84M+14.9% | $338.01M+18.6% | ||
| —— | —— | —— | $2.16M— | $2.1M— | ||
| -$466.61M— | -$377.96M— | —— | —— | —— | ||
| $293.78M+4.1% | $289.5M+3.3% | $285.67M+2.6% | $284.01M+2.3% | $282.08M+1.6% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | -$262.57M-12.0% | ||
| $350K+241% | $391K+208% | -$446K— | -$17K— | -$249K— | ||
| —— | —— | —— | —— | —— | ||
| $105.8M+0.8% | $110.96M+5.5% | $106.39M+5.2% | $104.1M+3.4% | $104.94M+4.3% | ||
| —— | $1.5M+7.7% | $1.47M+0.7% | $1.44M-5.7% | $1.42M-11.5% | ||
| $8.63M-5.8% | $7.99M-23.9% | $7.36M-37.9% | $7.76M-37.2% | $9.16M-25.9% | ||
| $7.1M+12.1% | $7.81M+43.4% | $7.61M+37.9% | $6.81M+35.8% | $6.34M+38.4% | ||
| $7.76M-49.4% | $7.32M-60.4% | $6.67M-74.1% | $4.1M-84.1% | $15.34M+47.4% | ||
| $5.62M— | $3.93M— | $2.18M— | —— | —— | ||
| $10.16M-15.3% | $11.45M-26.0% | $11M-21.5% | $13.62M+0.9% | $12M-17.7% | ||
| -$191K+97.2% | -$1.02M+73.5% | -$807K+80.5% | -$8.39M-67.0% | -$6.88M-20.4% | ||
| —— | —— | —— | -$24K— | -$26K— | ||
| -$1.09M-79.1% | -$1.05M-83.4% | -$765K— | -$673K— | -$607K— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | $1.83M-67.5% | ||
| —— | —— | —— | $2.16M— | $2.1M— | ||
| $5.2M-77.6% | $6.91M-68.1% | $5.82M-75.1% | $5M-77.4% | $23.25M+139% | ||
| $541.18M+275% | $452.93M+232% | $325.77M+116% | $161.44M— | $144.28M— | ||
| $21.49M+401% | $20.67M+482% | $16.22M+380% | $9.41M+292% | $4.29M+21.8% | ||
| -$2.98M+51.5% | -$2.53M+57.4% | -$2.6M+56.3% | -$2.59M+57.3% | -$6.14M-32.2% | ||
| —— | —— | —— | —— | —— | ||
| $224.93M+170% | $227.78M+164% | $203.11M+187% | $73.93M+106% | $83.34M+2,522% | ||
| $2.1M+2.7% | $2.09M+2.8% | $2.08M+2.7% | $2.06M+2.7% | $2.05M+2.8% | ||
| $45.59M-8.0% | $41.52M-24.1% | $39.71M-34.1% | $42.92M-40.6% | $49.56M-36.7% | ||
| $1.7M— | $1.59M— | $3.65M— | $3.42M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Sabra Healthcare's cash flow data come from?
- Every line is extracted from Sabra Healthcare's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.